Teva Pharmaceutical Walk-in on 30th March 2024 for Multiple Positions


Teva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Teva Pharmaceuticals was the largest generic drug manufacturerer

Vacancy details:

  • Department: Researcher I/ Analytical Researcher I & Quality Analyst III
  • Qualification: B Pharm/ M Pharm/ M.Sc./ Ph.D
  • Experience: 2 – 8 years
  • Salary:₹Not Disclosed

Job Description: Greeting From Teva Pharmaceuticals Pharma pvt ltd!!!!!

Important Details :

  • Job Location: Ambernath
  • Post of date:28/03/2024
  • Selection Process: The selection will be on the basis of Interview.
  • Mode of Interview: Face to Face interview
  • Interview Rounds of Interview: HR

Walkin Interview Details:

1. Formulation Researcher I

3 to 8 years experience in Formulation Development of Solid Oral Dosage forms, exposure from Development & submission to regulatory agencies.

Experience in working in a regulated markets (US/EU/Canada)

Basic understanding on recent ICH, regulatory guidelines IP requirements, Bioequivalence, GMP, GLP, Quality & SOP, compliance

2. Analytical Researcher I

Min 4 to 8 years in Analytical method development, method validation & transfer, Instrumental method of analysis of Solid Oral dosages

Hands on experience on instruments Viz, GC, HPLC, ion Chromatography, UV & dissolution apparatus

• Knowledge of regulatory requirements for different markets (US/EU/Canada)

3. Quality Analyst III

10 plus years experience in QMS & Analytical Development

Experience in Quality assurance and review of Nitrosamines related documents

Qualification: B Pharm/ M Pharm/ M.Sc./ Ph.D

Job Location: Ambernath

SATURDAY, March 30th 10:00AM-03:00 PM

Venue: Teva Pharmaceuticals, Plot No: K-7, Additional Ambernath, Anandnagar MIDC, Ambernath East

Request to share the relevant profilesby Thursday, 28th March EOD to to



Leave a Reply

Your email address will not be published. Required fields are marked *